Your browser doesn't support javascript.
loading
Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot.
Reuter, Miriam S; Chaturvedi, Rajiv R; Jobling, Rebekah K; Pellecchia, Giovanna; Hamdan, Omar; Sung, Wilson W L; Nalpathamkalam, Thomas; Attaluri, Pratyusha; Silversides, Candice K; Wald, Rachel M; Marshall, Christian R; Williams, Simon G; Keavney, Bernard D; Thiruvahindrapuram, Bhooma; Scherer, Stephen W; Bassett, Anne S.
Afiliação
  • Reuter MS; CGEn (M.S.R.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Chaturvedi RR; Center for Applied Genomics (M.S.R., G.P., O.H., W.W.L.S., T.N., C.R.M., B.T., S.W.S.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Jobling RK; Program in Genetics and Genome Biology (M.S.R., S.W.S.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Pellecchia G; Labatt Family Heart Center (R.R.C., R.M.W.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Hamdan O; Ted Rogers Center for Heart Research, Cardiac Genome Clinic (R.R.C., R.K.J.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Sung WWL; Ontario Fetal Center, Mount Sinai Hospital, Toronto, ON, Canada (R.R.C.).
  • Nalpathamkalam T; Ted Rogers Center for Heart Research, Cardiac Genome Clinic (R.R.C., R.K.J.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Attaluri P; Division of Clinical and Metabolic Genetics (R.K.J.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Silversides CK; Genome Diagnostics, Department of Paediatric Laboratory Medicine (R.K.J., C.R.M.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Wald RM; Center for Applied Genomics (M.S.R., G.P., O.H., W.W.L.S., T.N., C.R.M., B.T., S.W.S.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Marshall CR; Center for Applied Genomics (M.S.R., G.P., O.H., W.W.L.S., T.N., C.R.M., B.T., S.W.S.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Williams SG; Center for Applied Genomics (M.S.R., G.P., O.H., W.W.L.S., T.N., C.R.M., B.T., S.W.S.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Keavney BD; Center for Applied Genomics (M.S.R., G.P., O.H., W.W.L.S., T.N., C.R.M., B.T., S.W.S.), The Hospital for Sick Children, Toronto, ON, Canada.
  • Thiruvahindrapuram B; Medical Genomics Program, Department of Molecular Genetics (P.A.), University of Toronto.
  • Scherer SW; Division of Cardiology, Department of Medicine, Toronto Congenital Cardiac Center for Adults at the Peter Munk Cardiac Center (C.K.S., R.M.W., A.S.B.), and Toronto General Research Institute, University Health Network, ON, Canada.
  • Bassett AS; Labatt Family Heart Center (R.R.C., R.M.W.), The Hospital for Sick Children, Toronto, ON, Canada.
Circ Genom Precis Med ; 14(4): e003410, 2021 08.
Article em En | MEDLINE | ID: mdl-34328347
BACKGROUND: Tetralogy of Fallot (TOF)-the most common cyanotic heart defect in newborns-has evidence of multiple genetic contributing factors. Identifying variants that are clinically relevant is essential to understand patient-specific disease susceptibility and outcomes and could contribute to delineating pathomechanisms. METHODS: Using a clinically driven strategy, we reanalyzed exome sequencing data from 811 probands with TOF, to identify rare loss-of-function and other likely pathogenic variants in genes associated with congenital heart disease. RESULTS: We confirmed a major contribution of likely pathogenic variants in FLT4 (VEGFR3 [vascular endothelial growth factor receptor 3]; n=14) and NOTCH1 (n=10) and identified 1 to 3 variants in each of 21 other genes, including ATRX, DLL4, EP300, GATA6, JAG1, NF1, PIK3CA, RAF1, RASA1, SMAD2, and TBX1. In addition, multiple loss-of-function variants provided support for 3 emerging congenital heart disease/TOF candidate genes: KDR (n=4), IQGAP1 (n=3), and GDF1 (n=8). In total, these variants were identified in 63 probands (7.8%). Using the 26 composite genes in a STRING protein interaction enrichment analysis revealed a biologically relevant network (P=3.3×10-16), with VEGFR2 (vascular endothelial growth factor receptor 2; KDR) and NOTCH1 (neurogenic locus notch homolog protein 1) representing central nodes. Variants associated with arrhythmias/sudden death and heart failure indicated factors that could influence long-term outcomes. CONCLUSIONS: The results are relevant to precision medicine for TOF. They suggest considerable clinical yield from genome-wide sequencing, with further evidence for KDR (VEGFR2) as a congenital heart disease/TOF gene and for VEGF (vascular endothelial growth factor) and Notch signaling as mechanisms in human disease. Harnessing the genetic heterogeneity of single gene defects could inform etiopathogenesis and help prioritize novel candidate genes for TOF.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetralogia de Fallot / Predisposição Genética para Doença / Mapas de Interação de Proteínas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Newborn Idioma: En Revista: Circ Genom Precis Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tetralogia de Fallot / Predisposição Genética para Doença / Mapas de Interação de Proteínas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Newborn Idioma: En Revista: Circ Genom Precis Med Ano de publicação: 2021 Tipo de documento: Article